Development and validation of blood-based predictive biomarkers for response to PD- (L)-1 checkpoint inhibitors: Evidence of a universal systemic core of 3D immunogenetic profiling across multiple oncological indications

Category Primary study
JournalJournal of Clinical Oncology
Year 2022
This article has no abstract
Epistemonikos ID: a01812cc2d1cb7a5e0f862653e514ccac4f3ac51
First added on: Feb 15, 2025